Correlation Between AVROBIO and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AVROBIO and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVROBIO and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVROBIO and Acumen Pharmaceuticals, you can compare the effects of market volatilities on AVROBIO and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVROBIO with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVROBIO and Acumen Pharmaceuticals.
Diversification Opportunities for AVROBIO and Acumen Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between AVROBIO and Acumen is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding AVROBIO and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and AVROBIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVROBIO are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of AVROBIO i.e., AVROBIO and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between AVROBIO and Acumen Pharmaceuticals
If you would invest 240.00 in Acumen Pharmaceuticals on September 4, 2024 and sell it today you would lose (5.00) from holding Acumen Pharmaceuticals or give up 2.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
AVROBIO vs. Acumen Pharmaceuticals
Performance |
Timeline |
AVROBIO |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acumen Pharmaceuticals |
AVROBIO and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AVROBIO and Acumen Pharmaceuticals
The main advantage of trading using opposite AVROBIO and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVROBIO position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.AVROBIO vs. Ocean Biomedical | AVROBIO vs. Enveric Biosciences | AVROBIO vs. Elevation Oncology | AVROBIO vs. Zura Bio Limited |
Acumen Pharmaceuticals vs. Candel Therapeutics | Acumen Pharmaceuticals vs. Cingulate Warrants | Acumen Pharmaceuticals vs. Unicycive Therapeutics | Acumen Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |